Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-06-04 Purchase |
2025-06-06 08:44 am |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director |
2,268 | $13.34 | $30,247 | 8,852,607 (Indirect Direct) |
View |
| 2025-05-21 Purchase |
2025-05-23 4:04 pm |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director |
5,040 | $13.65 | $68,821 | 8,850,339 (Indirect Direct) |
View |
| 2025-05-15 Purchase |
2025-05-19 4:14 pm |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director |
2,520 | $13.62 | $34,317 | 8,845,299 (Indirect Direct) |
View |
| 2025-05-13 Purchase |
2025-05-15 4:18 pm |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director |
8,674 | $13.76 | $119,352 | 8,842,779 (Indirect Direct) |
View |
| 2025-05-09 Purchase |
2025-05-13 4:11 pm |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director |
6,300 | $13.6 | $85,691 | 8,834,105 (Indirect Direct) |
View |
| 2025-03-14 Purchase |
2025-03-18 5:04 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
549 | $44.11 | $24,214 | 3,735,584 (Indirect) |
View |
| 2025-03-10 Purchase |
2025-03-12 4:51 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
2,298 | $43.31 | $99,518 | 3,735,035 (Indirect) |
View |
| 2025-03-06 Purchase |
2025-03-10 5:12 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
1,915 | $43.69 | $83,661 | 3,732,737 (Indirect) |
View |
| 2025-03-04 Purchase |
2025-03-06 5:30 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
1,602 | $45.4 | $72,724 | 3,730,822 (Indirect) |
View |
| 2024-09-18 Purchase |
2024-09-20 4:39 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
115 | $37.4 | $4,301 | 3,729,220 (Indirect) |
View |
| 2024-09-16 Purchase |
2024-09-17 8:09 pm |
MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner |
625,000 | $16 | $10,000,000 | 4,552,774 (Indirect) |
View |
| 2024-09-06 Purchase |
2024-09-10 5:04 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
230 | $41.58 | $9,563 | 3,729,105 (Indirect) |
View |
| 2024-04-04 Purchase |
2024-04-08 4:22 pm |
HilleVax Inc. | HLVX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N Heron Patrick J 10% Owner |
8,850 | $14.5 | $128,325 | 8,544,187 (Direct) |
View |
| 2024-03-04 Purchase |
2024-03-06 4:28 pm |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director |
21,052 | $9.5 | $199,994 | 8,817,666 (Indirect Direct) |
View |
| 2023-11-09 Purchase |
2023-11-14 4:35 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
2,910 | $28.3 | $82,353 | 3,728,875 (Indirect) |
View |
| 2023-10-24 Purchase |
2023-10-26 4:09 pm |
Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N Heron Patrick J 10% Owner |
80,000 | $2.5 | $200,000 | 8,827,261 (Indirect Direct) |
View |
| 2023-09-13 Purchase |
2023-09-15 4:56 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
2,625 | $31.02 | $81,425 | 3,725,965 (Indirect) |
View |
| 2023-09-11 Purchase |
2023-09-13 4:39 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
8,437 | $30.44 | $256,791 | 3,723,340 (Indirect) |
View |
| 2023-08-31 Purchase |
2023-09-05 12:51 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director 10% Owner |
147,991 | $26.25 | $3,884,764 | 3,714,903 (Indirect) |
View |
| 2022-08-05 Purchase |
2022-08-09 4:34 pm |
Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N Heron Patrick J 10% Owner |
250,000 | $20 | $5,000,000 | 8,738,574 (Indirect Direct) |
View |
| 2022-05-03 Purchase |
2022-05-03 4:23 pm |
HilleVax Inc. | HLVX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N Heron Patrick J 10% Owner |
1,764,706 | $17 | $30,000,002 | 8,535,337 (Direct) |
View |
| 2022-02-11 Purchase |
2022-02-15 5:00 pm |
ALPINE IMMUNE SCIENCES INC. | ALPN | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Heron Patrick J Topper James N 10% Owner |
112,665 | $7.1006 | $799,989 | 1,484,115 (Direct) |
View |
| 2021-09-17 Sale |
2021-09-21 1:54 pm |
ALPINE IMMUNE SCIENCES INC. | ALPN | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Heron Patrick J Topper James N FHM LIFE SCIENCES VIII L.P. 10% Owner |
1,200,000 | $0 | $0 | 2,571,450 (Direct) |
View |
| 2021-07-20 Purchase |
2021-07-20 5:54 pm |
Imago BioSciences Inc. | IMGO | Heron Patrick J FHM VII L.L.C. FHM VII L.P. Frazier Healthcare VII L.P. Frazier Healthcare VII-A L.P. Director |
187,500 | $16 | $3,000,000 | 2,312,331 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-05 Option Award |
2025-06-06 08:02 am |
N/A 2035-06-05 |
MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner |
16,000 | $0 | 16,000 (Direct) |
View |
| 2025-05-29 Exercise |
2025-06-02 7:39 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
5,703 | $0 | 3,751,532 (Direct) |
View |
| 2025-05-29 Option Award |
2025-06-02 7:39 pm |
N/A 2035-05-28 |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
10,245 | $0 | 3,751,532 (Direct) |
View |
| 2024-06-06 Option Award |
2025-04-30 07:00 am |
N/A 2034-06-05 |
HilleVax Inc. | HLVX | Heron Patrick J Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2024-09-16 Conversion |
2024-09-17 8:09 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner |
51,147,891 | $0 | 4,552,774 (Indirect) |
View |
| 2024-09-12 Option Award |
2024-09-13 5:04 pm |
N/A 2034-09-11 |
MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner |
15,963 | $0 | 15,963 (Direct) |
View |
Ownership |
2024-09-12 7:20 pm |
N/A N/A |
MBX Biosciences Inc. | MBX | Heron Patrick J Director 10% Owner |
0 | $0 | 3,927,774 (Indirect) |
View |
| 2024-06-14 Option Award |
2024-06-18 4:52 pm |
N/A 2034-06-14 |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner |
37,191 | $0 | 45,878 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:22 pm |
N/A 2034-06-04 |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director |
14,482 | $0 | 14,482 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 5:38 pm |
N/A 2033-06-11 |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director 10% Owner |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 6:33 pm |
N/A 2033-06-06 |
HilleVax Inc. | HLVX | Heron Patrick J Director 10% Owner |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:16 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner |
16,595 | $0 | 20,907 (Direct) |
View |
| 2022-08-19 Option Award |
2022-08-23 4:35 pm |
N/A 2032-08-18 |
HilleVax Inc. | HLVX | Heron Patrick J Director 10% Owner |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:57 pm |
N/A 2032-06-01 |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director 10% Owner |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:53 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner |
16,108 | $0 | 16,108 (Direct) |
View |
| 2022-05-03 Conversion |
2022-05-03 4:23 pm |
N/A N/A |
HilleVax Inc. | HLVX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N Heron Patrick J 10% Owner |
2,736,234 | $13.6 | 8,535,337 (Direct) |
View |
| 2022-05-03 Conversion |
2022-05-03 4:23 pm |
N/A N/A |
HilleVax Inc. | HLVX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N Heron Patrick J 10% Owner |
37,212,796 | $0 | 8,535,337 (Direct) |
View |
Ownership |
2022-04-28 9:37 pm |
N/A N/A |
HilleVax Inc. | HLVX | Frazier Life Sciences X L.P. FHMLS X L.P. FHMLS X L.L.C. Topper James N Heron Patrick J 10% Owner |
0 | $0 | 6,770,631 (Direct) |
View |
| 2021-09-17 Option Award |
2021-09-21 1:54 pm |
N/A N/A |
ALPINE IMMUNE SCIENCES INC. | ALPN | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Heron Patrick J Topper James N FHM LIFE SCIENCES VIII L.P. 10% Owner |
1,200,000 | $0 | 2,571,450 (Direct) |
View |
| 2021-07-20 Conversion |
2021-07-20 5:54 pm |
N/A N/A |
Imago BioSciences Inc. | IMGO | Heron Patrick J FHM VII L.L.C. FHM VII L.P. Frazier Healthcare VII L.P. Frazier Healthcare VII-A L.P. Director |
2,783,774 | $0 | 2,312,331 (Indirect) |
View |
| 2021-07-15 Option Award |
2021-07-19 4:10 pm |
N/A 2031-07-14 |
Imago BioSciences Inc. | IMGO | Heron Patrick J Director |
23,809 | $0 | 23,809 (Direct) |
View |